Shenzhen AiNear Cornea Engineering

Shenzhen AiNear Cornea Engineering is a pioneering regenerative medicine company focused on the development and commercialization of tissue-engineered products for ophthalmology. The company's flagship product, Acornea, is the world's first bio-engineered cornea to complete clinical trials and receive regulatory approval from the China National Medical Products Administration (NMPA). Acornea utilizes decellularized porcine corneal stroma to provide a safe and effective alternative to human donor corneas for treating corneal blindness. As a subsidiary of China Regenerative Medicine International Limited, the company continues to advance clinical applications of its proprietary decellularization technology to address the global shortage of donor tissues.